Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

» Andere revante producten voor Scalda studenten en medewerkers.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Netherlands Heart Journal
Gepubliceerd in:

01-11-2009 | Case report

Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report

Auteurs: R. V. H. P. Huijskes, K. Hoogenberg, A. C. P. Wiesfeld, M. E. J. Pijl, I. C. van Gelder

Gepubliceerd in: Netherlands Heart Journal | Uitgave 11/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Extract

Cardiomyopathy is in general a late complication of ischaemic heart disease or significant valvular disease. However, it is not uncommon to see normal coronary arteries and only minor valvular heart disease, hence categorised as idiopathic cardiomyopathy. …
vorige artikel Remote monitoring of implanted cardiac devices: a plea for a nationwide exploration
volgende artikel A very rare image in cardiology: posterolateral artery myocardial bridge
Literatuur
1.
Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, Otazua P, et al. MR quantification of hepatic iron concentration. Radiology. 2004;230:479–84.
2.
Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G—> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211–8.
3.
Mahon NG, Coonar AS, Jeffery S, Coccolo F, Akiyu J, Zal B, et al. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart. 2000;84:541–7.
4.
Grosberg SJ. Hemochromatosis and heart failure: presentation of a case with survival after three years' treatment by repeated venesection. Ann Intern Med. 1961;54:550–9.
5.
Menahem S, Salmon AP, Dennett X. Haemochromatosis presenting as severe cardiac failure in a young adolescent. Int J Cardiol. 1990; 29:86–9.
6.
Oliveira e Silva A, Maciel L, Fernandes E, Pina R, Candeias O, de Freitas F. [Refractory heart failure in a 26-year-old woman with idiopathic hemochromatosis].Rev Port Cardiol. 1994;13:771–5.
7.
Short EM, Winkle RA, Billingham ME. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection. Am J Med. 1981;70:1275–9.
8.
Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769–78.
9.
Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol. 1998;103:842–5.
10.
Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001;285:2216–22.
11.
Bassett ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology. 1984;87:628–33.
12.
Chapman BA, Horton DM, Burt MJ, Romeril KR, Walmsley TA, Grant SJ, et al. Investigation of subjects with abnormal iron studies: role of the hepatic iron index. N Z Med J. 1994;107:504–7.
13.
Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol. 2001;80:737–44.
14.
Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107–19.
15.
Caines AE, Kpodonu J, Massad MG, Chaer R, Evans A, Lee JC, et al. Cardiac transplantation in patients with iron overload cardiomyopathy. J Heart Lung Transplant. 2005;24:486–8.
Metagegevens
Titel
Phlebotomies as a treatment of serious heart failure due to haemochromatosis: a case report
Auteurs
R. V. H. P. Huijskes
K. Hoogenberg
A. C. P. Wiesfeld
M. E. J. Pijl
I. C. van Gelder
Publicatiedatum
01-11-2009
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 11/2009
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086299

Andere artikelen Uitgave 11/2009

Gender differences in adult congenital heart disease

  • Original article

Methods for analysing cardiovascular studies with repeated measures

  • Review article

Imaging atherosclerotic plaque composition with intracoronary optical coherence tomography

  • Interuniversity Cardiology Institute of the Netherlands

Remote monitoring of implanted cardiac devices: a plea for a nationwide exploration

  • Debate article

Thrombus Aspiration during Percutaneous coronary intervention in Acute non-ST-elevation myocardial infarction Study (TAPAS II)-Study design

  • Study design article

Founder mutations in the Netherlands

  • Review article